Stock listing
OTC:ERGO Entia Biosciences Inc Stock
Follow Entia Biosciences Inc into a list and get an email when it puts out news.
Share price · OTC:ERGO
$0.0023 USD 0.0000 (0.0%)
Close on Nov 13, 2026
- Day range
- $0.0023 – $0.0023 USDNov 13, 2026
- Market cap
- —Left out: too few shares trade to back it
- 52-week range
- $0.0001 – $0.0402 USDLowest and highest trades, Nov 14, 2025 – Nov 13, 2026
- Traded on an average day
- $0 USDMedian day 0 shares · 53 days with no trades · last 3 months, Aug 13, 2026 – Nov 13, 2026

Daily closes
Last 3 months, Aug 13, 2026 – Nov 13, 2026 · OTC:ERGO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0023 | 0.0000 | 0.0% | $0.0023 | $0.0023 | $0.0023 | 0 | |
| $0.0023 | +0.0013 | +130.0% | $0.0023 | $0.0023 | $0.0023 | 5,000 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 550 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | 0.0000 | 0.0% | $0.0010 | $0.0010 | $0.0010 | 0 | |
| $0.0010 | +0.0002 | +25.0% | $0.0010 | $0.0010 | $0.0010 | 13,500 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0002 | $0.0008 | $0.0002 | 150 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | 0.0000 | 0.0% | $0.0008 | $0.0008 | $0.0008 | 0 | |
| $0.0008 | +0.0006 | +300.0% | $0.0008 | $0.0008 | $0.0008 | 2,000 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 |
Splits
1 split · OTC:ERGO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation |
- Ticker
- OTC:ERGO
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Latest news
Entia Biosciences Inc on 6ix
- News releases
- 8 in all · newest Feb 24, 2017 · oldest 2015
Valuation
price Nov 13, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- -0.04
Financials
Annual, in USD
Income statement
| Line | FY2022 | FY2021 | FY2020 | FY2019 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 265.5K | 346.9K | 656.3K | 314.7K | 369.3K | 403.3K | ||||
| Cost of revenue | 91.5K | 131.0K | 245.5K | 131.1K | 107.5K | 132.7K | ||||
| Gross profit | 174.0K | 215.9K | 410.9K | 183.6K | 261.8K | 270.6K | ||||
| Research and development | 37.8K | 73 | 25 | 28 | 58 | |||||
| Selling, general and administrative | 1.25M | 2.00M | 2.06M | 2.69M | 1.30M | 1.54M | ||||
| Operating income | -1.17M | -1.92M | -1.77M | -2.68M | -1.08M | -1.47M | ||||
| Depreciation and amortization | 228.5K | 236.6K | 206.3K | 171.9K | 17.7K | 32.0K | 38.0K | 36.0K | 21.5K | 15.1K |
| EBITDA | -1.15M | -1.88M | -1.73M | -2.65M | -1.06M | -1.46M | ||||
| Interest expense | 83.5K | 172.6K | 339.7K | 144.7K | 262.9K | 338.9K | ||||
| Income before tax | -1.40M | -2.26M | -2.30M | -3.10M | -1.26M | -1.73M | ||||
| Income tax | 76.9K | 149.3K | 339.7K | 144.7K | 262.9K | 338.9K | ||||
| Net income | -1.47M | -2.41M | -2.64M | -3.25M | -1.53M | -1.73M | ||||
| Earnings per share, basic | -0.05 | -0.10 | -0.28 | -0.43 | -0.21 | -0.28 |
Balance sheet
| Line | FY2022 | FY2021 | FY2020 | FY2019 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 76.0K | 24.1K | 99.5K | 36.9K | 13.1K | 16.6K | ||||
| Short-term investments | 0 | 0 | 0 | 0 | ||||||
| Receivables | 7.97K | 7.10K | 243.8K | 15.2K | 66.5K | 36.3K | ||||
| Inventory | 69.8K | 40.3K | 95.4K | 138.9K | 132.1K | 173.6K | ||||
| Current assets | 234.3K | 128.3K | 484.7K | 225.5K | 244.2K | 258.4K | ||||
| Property, plant and equipment | 18.3K | 32.7K | 43.1K | 62.1K | ||||||
| Goodwill | 0 | 0 | 0 | 0 | ||||||
| Total assets | 439.1K | 448.6K | 870.7K | 631.1K | 463.0K | 404.9K | ||||
| Accounts payable | 652.7K | 595.3K | 380 | 614 | 431 | 36.3K | ||||
| Current liabilities | 2.11M | 1.24M | 987.2K | 1.58M | 1.11M | 599.7K | ||||
| Long-term debt | 300.1K | 0 | 0 | 0 | ||||||
| Total debt | 1.05M | 279.2K | 418.1K | 423.0K | 456.3K | 332.8K | ||||
| Total liabilities | 2.41M | 1.24M | 987.2K | 1.58M | 1.11M | 664.7K | ||||
| Shareholders' equity | -1.97M | -791.2K | -116.5K | -949.6K | -648.3K | -259.8K | ||||
| Shares outstanding | 28.1M | 28.1M | 28.1M | 28.1M | 28.1M | 24.3M | 9.44M | 7.53M | 7.30M | 6.26M |
Cash flow
| Line | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|
| Cash from operations | -715.1K | -536.6K | -680.3K | -766.7K | -314.6K | -208.7K |
| Capital spending | -7.12K | -21.3K | -45.5K | -64.6K | -63.3K | -44.0K |
| Free cash flow | -722.2K | -557.9K | -725.7K | -831.3K | -377.9K | -252.8K |
| Cash from investing | -7.12K | -21.3K | -45.5K | -64.6K | -63.3K | -31.1K |
| Cash from financing | 774.1K | 482.5K | 788.3K | 855.1K | 374.4K | 191.4K |
| Dividends paid | 0 | 0 | 0 | 0 | ||
| Share buybacks | 0 | 0 | 0 | 0 | ||
| Change in cash | 51.9K | -75.3K | 62.6K | 23.8K | -3.56K | -48.4K |
Cap table
Built by 6ix from Entia Biosciences Inc’s releases
- Common shares
- 33,660,947
- Fully diluted
- 33,660,947
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 33,660,947 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 33,660,947 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Marvin S Md Hausman Other companies: Raptor Pharmaceutical Corp (Director · Aug 23, 2006 – Aug 23, 2006 · Past); GT Biopharma, Inc. (President & CEO, Director · Aug 1, 2006 – Dec 31, 2007 · Past) | Chairman, CSTO, Director · Nov 20, 2012 – Feb 14, 2017 · Past |
| Devin D Andres | Chief Operating Officer · Feb 20, 2013 – Apr 24, 2015 · Past |
| Philip A Sobol | Director · May 18, 2012 – Apr 24, 2015 · Past |
Log in to ask 6ix AI your own questions about Entia Biosciences Inc.